fda bans tirzepatide compounded Compounded versions of tirzepatide (Mounjaro, Zepbound) containing vitamin B12 pose a potential FDA Drug Recalls and Warnings:

Localized site discoloration at high-dose repeated injection Sparse community reports describe faint bluish or brownish discoloration at sites injected repeatedly with high-dose GHK-Cu (above community-typical doses)

A sleep medication doesnt fix the anxiety causing the sleep problem

Store the lyophilised GHK-Cu 50mg peptide in a cool dry place at 28C, away from direct sunlight and heat

For the research frontier of metabolic peptide therapy, retatrutide is the winner

Archived from the original on June 13, 2022

Our Aspen team can verify your benefits and manage the prior authorization process to streamline your treatment